Advertisement
Clinical Research and Public HealthIn-Press PreviewGeneticsNeuroscience
Open Access |
10.1172/JCI194555
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by
Lang, C.
in:
PubMed
|
Google Scholar
|
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by
Guillot, S.
in:
PubMed
|
Google Scholar
|
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Lule, D. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Balz, L. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Knehr, A. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Weydt, P. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Dorst, J. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Kandler, K. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Müller, H. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Kassubek, J. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Wassermann, L. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Da Cruz, S. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by
Roselli, F.
in:
PubMed
|
Google Scholar
|
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Ludolph, A. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Bolborea, M. in: PubMed | Google Scholar
1Department of Neurology, University Hospital of Ulm, Ulm, Germany
2University of Strasbourg, INSERM, Strasbourg Translational Neuroscience & Psychiatry STEP – CRBS, UMR-S 1329, Strasbourg, France
3VIB-KU Leuven Center for Brain and Disease Research and Department of Neuro, KU Leuven, Leuven, Belgium
4Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Ulm, Germany
Find articles by Dupuis, L. in: PubMed | Google Scholar
Published November 6, 2025 - More info
BACKGROUND. Amyotrophic lateral sclerosis (ALS), the major adult-onset motor neuron disease, is preceded by an early period unrelated to motor symptoms, including altered sleep, with increased wakefulness and decreased deep NREM. Whether these alterations in sleep macroarchitecture are associated with, or even precede abnormalities in sleep-related EEG features remains unknown.
METHODS. Here, we characterised sleep microarchitecture using polysomnography in patients with ALS (n=33) and controls (n=32), and in asymptomatic carriers of SOD1 or C9ORF72 mutations (n=57) and non-carrier controls (n=30). Patients and controls with factors that could confound sleep structure, including respiratory insufficiency, were prospectively excluded. Results were complemented in three ALS mouse models (Sod1G86R , Fus∆NLS/+ and TDP-43Q331K ).
RESULTS. We observed a brain-wide reduction in the density of sleep spindles, slow oscillations and K-complexes in both early-stage ALS patients and presymptomatic gene carriers. These defects in sleep spindles and slow oscillations correlate with cognitive performance in both cohorts, particularly with scores on memory, verbal fluency and language function. Alterations in sleep microarchitecture were replicated in three mouse models and decreases in sleep spindles were rescued following intracerebroventricular supplementation of MCH or by the oral administration of a dual orexin receptor antagonist.
CONCLUSION. Sleep microarchitecture is associated with cognitive deficits and is causally linked to aberrant MCH and orexin signalling in ALS.
FUNDING. This work was funded by Agence Nationale de la Recherche (ANR-24-CE37-4064, ANR-10-IDEX-0002, ANR-20-SFRI-0012), Fondation Thierry Latran, Association Francaise de Recherche sur la sclérose latérale amyotrophique, Association Française contre les Myopathies (#28944), TargetALS and JPND.